Nucleai

Join us at Technology Networks' Online Symposium, The Spatial Biology Revolution 2024 on December 4-5. On December 4 at 14:05 ET, Dr. Jason Reeves, Nucleai's Director of Application Science, will share insights on how AI-driven spatial biomarkers and diagnostics are shaping the development of ADCs, bispecifics, and IO combinations. Don’t miss this deep dive into the future of precision medicine! Register here ➡️ https://hubs.li/Q02ZxBgW0 #PresicsionMedicine #SpatialBiology #SpatialBiomarkers #Biomarkers #CDx #ADCs #Multispecifics #Immunotherapy #DigitalPathology #AIPathology

📢 We're proud to share that Dr. Ettai Markovits, our Director of Biomedical Research, will be presenting at Multi-Omics 2024 in Brisbane! Ettai will showcase Nucleai’s deep learning-based multiplex imaging analysis pipeline, highlighting collaborative research with Dr. Arutha Kulasinghe and Dr. David Rimm. This work demonstrates how AI-powered spatial biomarkers can enhance immunotherapy outcomes for NSCLC patients and advance precision medicine. Meet us there! 🗓 Tuesday, December 3 | 10:35 AM 📍 Computational Biology Session https://hubs.li/Q02ZtQzC0 #SpatialBiomarkers #Immunotherapy #SpatialBiology #PrecisionMedicine #Biomarkers #NSCLC #LungCancer #MultiOmics24

Great read on the transformative potential of highly multiplexed tissue imaging (HMTI) in precision oncology. The recent Cancer Discovery review underscores its role in analyzing complex tumor ecosystems and advancing biomarker discovery. As HMTI gains traction in clinical settings, the integration of AI-driven multiplex analysis tools becomes increasingly essential. Leveraging such technologies can provide actionable spatial insights that predict therapy responses and inform treatment decisions, thereby accelerating biomarker discovery and advancing precision medicine. https://hubs.li/Q02XNxqJ0 #Biomarkers #SpatialBiomarkers #PrecisionOncology #Multiplex #mIF #DigitalPathology #AIPathology

Our team will be at the Lunaphore (a Bio-Techne brand) booth #701 at #SITC2024! Stop by today from 11:00-11:15 am or 3:10-3:25 pm to discuss AI-powered spatial biomarkers in immunotherapy. Looking forward to connecting! #SpatialBiomarkers #DigitalPathology #AIPathology #Immunotherapy #SITC24 #PrecisionOncology Society for Immunotherapy of Cancer (SITC), Ettai Markovits, Meir Azulay

Did you catch Dr. Ettai Markovits and Dr. Arutha Kulasinghe by our poster today at #SITC24? We're presenting pivotal findings on immune and metabolic profiles in NSCLC, using Nucleai’s AI biomarker platform to pinpoint combination therapies that address treatment resistance and improve patient outcomes. Got questions? Connect with us to learn more! https://hubs.li/Q02XCNyk0 #ImmunoOncology #immunotherapy #PrecisionOncology #SpaitialBiomarkers #DigitalPathology #AIPathology Society for Immunotherapy of Cancer (SITC)

🎬 We’re live at #SITC24! Our Biomedical Director, Dr. Ettai Markovits, is live, presenting Poster #117 on AI-powered spatial biomarker analysis in collaboration with Lunaphore (a Bio-Techne brand) and Dr. Paolo A. Ascierto. This research focuses on immunotherapy-treated metastatic melanoma patients, highlighting the role of spatial biomarkers in driving personalized treatment. Check out our two featured posters: 📌 Poster #109: Immuno-metabolic spatial signature predicting immunotherapy response in NSCLC 📌 Poster #117: Novel multiplex imaging & AI-powered spatial biomarker analysis in immunotherapy-treated melanoma Meet the Nucleai team at the Lunaphore booth (#701) tomorrow! 📅 Meet the experts 🕚 11:00 – 11:15 am 🕒 3:10 – 3:25 pm https://hubs.li/Q02XzSql0 #SpatialBiomarkers #ImmunoOncology #Immunotherapy #biomarkers #NSCLC #melanoma #precisiononcology #digitalpathology #AIPathology Society for Immunotherapy of Cancer (SITC)

Day 2 at #WorldADC in San Diego! Missed our talk? Stop by booth 607 to discuss AI-powered spatial scoring for ADCs and explore how we’re advancing antibody-drug conjugates. https://lnkd.in/gjTrVzcv #WorldADC24 #spatialbiomarkers #AIPathology #DigitalPathology #precisiononcology #ADCs {{linkedin_mention(urn:li:person:lbadpaSsYt|Martin Koch)}}, {{linkedin_mention(urn:li:person:rFcqZee2kk|Jason Reeves)}}

Discover Nucleai at SITC 2024! 📢 Join us to explore our latest advances in spatial biomarker solutions for immuno-oncology. Our featured poster presentations highlight breakthroughs in patient stratification, treatment resistance mechanisms, and personalized immunotherapy approaches for NSCLC and melanoma. Learn how AI-driven spatial biomarker solutions are transforming immuno-oncology for more precise and effective treatment. 📅 Friday, Nov 8 📌 Poster #109: Immuno-metabolic spatial signature predicting immunotherapy response in NSCLC 📌 Poster #117: Novel multiplex imaging & AI-powered spatial biomarker analysis in immunotherapy-treated melanoma 🔗 Read the full press release https://lnkd.in/gX2-m92W 📅 Book a meeting with our team to dive deeper into these findings! https://lnkd.in/gzaYX2xF #SITC24 #SpatialBiomarkers #ImmunoOncology #Immunotherapy #Biomarkers #DigitalPathology #AIPathology Lunaphore (a Bio-Techne brand)

Jason Reeves, our Director of Application Science, took the stage at #WorldADC! 🎤 Sharing how Nucleai’s AI-driven Spatial Biomarkers are advancing ADC therapies. Missed the session or have questions? Stop by booth 607 and connect with our team! https://bit.ly/3AsHqff #SaptialBiomarkers #AIPathology #DigitalPathology #PrecisionMedicine #ADCs #AntibodyDrugConjuages #WorldADC24

We’re thrilled to announce two groundbreaking studies to be presented this weekend at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting, developed in collaboration with Prof. Paolo A. Ascierto and Lunaphore (a Bio-Techne brand), Dr. Arutha Kulasinghe of The University of Queensland, and Dr. David Rimm from Yale University. These studies highlight critical advancements in patient stratification, treatment resistance mechanisms, and personalized immunotherapy approaches for non-small cell lung cancer (NSCLC) and melanoma. With two abstracts focused on pivotal areas of disease research, Nucleai provides a comprehensive look at how AI-driven spatial biomarker analysis can impact patient outcomes from diagnosis through treatment. The findings demonstrate how spatial biomarker analysis integrates effectively into biopharma and CRO workflows, particularly for immunotherapies. 🔗 Read the full press release to learn more about these transformative studies. Join us at SITC to discuss these advancements in immunotherapy! https://lnkd.in/gX2-m92W #spatialbiomarker #immunotherapy #SITC24 #biomarker #digitalpathology #precisiononcology